Because of the declining frequency of anaerobic bacteremia, routinely using half the collected blood volume for anaerobic culture has been challenged. There is no data indicating whether more clinically relevant isolates would be recovered if all or most of the given blood sample were cultured aerobically. In this two-part study, we reviewed cases of anaerobic bacteremia to determine what proportion occurred in situations when anaerobes would be expected and then estimated the yield of different culture approaches by reanalyzing the data from a large prospective clinical blood culture study. obvious source of infection, six were on high-dose steroids. Relative yields were compared for (i) one aerobic bottle and one anaerobic bottle (5 ml to each) for all blood cultures, (ii) two aerobic bottles (5 ml to each), or (iii) two aerobic bottles plus an extra anaerobic bottle (only for clinically suspected anaerobic sepsis) (5 ml to each). The third approach had the highest yield (475 isolates), because the routine use of two aerobic bottles recovered more Candida spp., members of the family Enterobacteriaceae, and nonfermenters than did the first approach (448 isolates) (P < 0.02), and clinically directed culturing for anaerobes would recover anaerobes missed with the second approach (458 isolates). Our data suggest that the use of two aerobic bottles with selective culturing for anaerobes could increase the number of clinically relevant isolates by at least 6% compared with the current practice of inoculating an aerobic bottle and an anaerobic bottle with equal volumes of blood.
Because of the declining frequency of anaerobic bacteremia, routinely using half the collected blood volume for anaerobic culture has been challenged. There is no data indicating whether more clinically relevant isolates would be recovered if all or most of the given blood sample were cultured aerobically. In this two-part study, we reviewed cases of anaerobic bacteremia to determine what proportion occurred in situations when anaerobes would be expected and then estimated the yield of different culture approaches by reanalyzing the data from a large prospective clinical blood culture study. The records of 61 patients who had an anaerobic isolate (excluding Propionibacterium species) recovered only from an anaerobic bottle were examined to define clinical settings in which such isolates occur. Fifty-six (92%) patients had clinically important isolates, and the source of infection was obvious at the time of culture in 47 of the 56 (84%). Of 56 patients, 36 (64%) had abdominal signs and symptoms, including 12 with recent abdominal surgery. Of nine patients without an obvious source of infection, six were on high-dose steroids. Relative yields were compared for (i) one aerobic bottle and one anaerobic bottle (5 ml to each) for all blood cultures, (ii) two aerobic bottles (5 ml to each), or (iii) two aerobic bottles plus an extra anaerobic bottle (only for clinically suspected anaerobic sepsis) (5 ml to each). The third approach had the highest yield (475 isolates), because the routine use of two aerobic bottles recovered more Candida spp., members of the family Enterobacteriaceae, and nonfermenters than did the first approach (448 isolates) (P < 0.02), and clinically directed culturing for anaerobes would recover anaerobes missed with the second approach (458 isolates). Our data suggest that the use of two aerobic bottles with selective culturing for anaerobes could increase the number of clinically relevant isolates by at least 6% compared with the current practice of inoculating an aerobic bottle and an anaerobic bottle with equal volumes of blood.
Over the past 15 years there has been a decline in the proportion of positive blood cultures that yield anaerobic bacteria, whereas the proportion with Candida spp. has increased (9, 10, 20, 23, 28, 35) . Consequently, the routine inoculation of an anaerobic bottle has been called into question (23, 28) . Data have not been presented, however, to estimate how many more clinically important isolates might be recovered if the entire blood sample were cultured aerobically, rather than routinely using half the sample for anaerobic culture.
We have retrospectively reviewed the charts of patients with anaerobic isolates found only in the anaerobic bottle at our medical center to define the clinical settings in which such bacteremia occurs in our hospital. By using these data and reanalyzing the results from a prospective multicenter blood culture study (34) , we present an estimate of the likely increase in clinically relevant isolates if blood were routinely inoculated into two aerobic bottles and if an anaerobic bottle was used only for patients at recognized risk for anaerobic bacteremia. (34) . In this study, 20 ml of blood was collected at the bedside and 5 ml was inoculated immediately into each of the four blood culture bottles. Only adequately (4 to 6 ml) filled bottles were analyzed for yield. Only isolates deemed clinically relevant were included in the analysis; contaminants were ignored. The overall recoveries of microorganisms from the two aerobic and two anaerobic bottles were comparable (34) . For the purposes of this study, the two systems were regarded as being equivalent, which enabled us to calculate the yield from various combinations (details above) of inoculated bottles. We arbitrarily chose the BACTEC anaerobic bottle for analysis of the yield from 5 ml of blood inoculated anaerobically. This system is equivalent to the BacT/Alert anaerobic system (34) . Two assumptions were made in estimating the yield for selective anaerobic blood culture on clinical grounds. First, the estimate of how many obligate anaerobes would be detected with the selective use of the anaerobic bottle was made by applying the proportion of patients at Duke University Medical Center with anaerobic bacteremia who had signs and symptoms at a site where anaerobes are expected (84% [see below]) to the yield from routinely using an anaerobic bottle in the prospective blood culture evaluation as described above. Second, credit was given only for recovering obligate anaerobes in the anaerobic bottle. (Table 1 ). Six of these nine patients had clinically significant aerobic organisms recovpatients were on high-dose steroids. Ten patients were ered from the aerobic bottle of the same set containing the neutropenic, and Clostridium spp. were recovered in nine. anaerobe isolate(s) (specifically, members of the family
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The four neutropenic patients who did not have signs and Enterobacteriaceae, 7 patients; Staphylococcus aureus, 2 symptoms suggesting a site where anaerobes could be ex- (9, 20, 23, 28) . All the reasons for this decrease are unknown, but many have been proposed: earlier recognition and treatment of anaerobic infection, empiric antimicrobial therapy with agents with anaerobic activity, changing patient populations, and preoperative use of agents before bowel surgery (9, 20, 23, 28) ; the last has data to support it (1). This decline has led some to question the routine use of half the blood volume for anaerobic culture and to suggest that anaerobic cultures be reserved for those clinical settings where anaerobes are known to be important (23, 28) . In our hospital, most (84%) patients with anaerobic bacteremia detected only in an anaerobic blood culture bottle had signs and symptoms indicating a site where anaerobes would be expected. This proportion is in close agreement (87 and 92%, respectively) with two recent reports (3, 20) . The majority of our isolates (64%) originated from the abdomen. Other reports have implicated the gastrointestinal tract as the source for 42 to 65% of anaerobic blood isolates (2, 3, 5, 14, 18, 20) . The other sites encountered were similar to those described previously (3, 5, 14, 18 (2, 14) , no specific information is provided about the presence or absence of symptoms. In Lombardi and Engleberg's blood culture series, two of the five patients with an unknown source were febrile neutropenic patients but there was no information regarding steroid therapy (20) . Almost all (9 of 10) of the neutropenic patients had Clostndium bacteremia, and C. tertium and C. septicum predominated. This association has been well-described (19, (29) (30) (31) . If 10 ml of blood is obtained for culture, more clinically important isolates would be recovered if the entire sample were cultured aerobically than are recovered by the current practice of culturing half anaerobically. This is because more members of the family Enterobacteriaceae, nonfermenters, and yeasts would be recovered from the blood which would otherwise have been incubated anaerobically. The current practice of equal division of blood for aerobic and anaerobic culture reduces the yield of significant aerobic isolates when the prevalence of anaerobic bacteremia is low.
If one has to choose between detecting more yeasts, members of the family Enterobacteniaceae, and nonfermenters and detecting more anaerobes, it appears to us that the former would have greater clinical utility. Antimicrobial susceptibilities of anaerobes are more reliably predictable than those of Enterobactenaceae or nonfermenters; several antimicrobial agents have almost universal activity for anaerobes (6, 7, 11, 12, 14, 15, 17, 24, 33) . Although it is true that some researchers have observed changes in the susceptibilities of anaerobic isolates (8, 13, 26) , susceptibility testing is seldom required for an individual patient, even though certain exceptions exist (15, 25) . Not all yeasts are susceptible to amphotericin B or fluconazole and the identification of a yeast isolate can be helpful in suggesting its likely susceptibility (4, 16, 21, 22, 27, 32, 36) . Neither identification nor susceptibility testing is possible if the isolate is by chance distributed in the half of the blood sample cultured in the inhospitable milieu of an anaerobic bottle.
The hope that more clinically relevant organisms would be recovered with the two aerobic bottle approach may not be realized if enough facultative anaerobic bacteria (e.g., streptococci, staphylococci, and members of the family Enterobacteriaceae) fail to grow because they were not inoculated into an anaerobic bottle. As Murray et al. (23) have indicated, the major benefit of the unvented bottle may be the recovery of facultative anaerobes that preferentially grow in anaerobic bottles. We observed some evidence for this ( Table 2 ). The total number of anaerobic isolates was 27, yet the routine use of an anaerobic bottle in addition to two aerobic bottles recovered 31 facultative anaerobic bacteria (12 staphylococci, 11 streptococci, and 8 Enterobacteriaceae [ Table 2 ]). We had no way of telling how many of these 31 isolates were obtained in settings where anaerobes could be expected, but it is reasonable to assume that some of the streptococcal and Enterobacteriaceae isolates would have been detected. Therefore, selective use of anaerobic cultures may recover clinically relevant facultative anaerobes in addition to most anaerobes.
Establishing and monitoring a policy for selective use of anaerobic blood cultures requires that logistical issues be addressed. Possible approaches include prepackaged collection kits with two aerobic bottles with a note of when anaerobic culture is indicated; specially trained blood culture teams; and arbitrarily restricting anaerobic bottles to certain wards, for example, colorectal and gynecologic surgical services.
Anaerobic cultures should be reserved for patients for whom there is clinical evidence of infection at a site where anaerobes are likely. Neutropenic patients on steroids represent a group for whom anaerobic cultures also should be considered even in the absence of symptoms referable to the abdomen (Table 1) . By our analysis, the routine aerobic culturing of the entire volume of 10 to 20 ml of blood from an independent venipuncture from an adult and the selective use of anaerobic blood cultures would likely increase the overall yield of clinically important isolates by about 6%. This approach is already common in pediatric patients where the prudent volume of available blood for culture is much less. Proof of our prediction requires an appropriately designed prospective clinical trial.
